XML 85 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
(LOSS) EARNINGS PER SHARE (Tables)
 9 Months Ended
Sep. 30, 2013
Earnings Per Share [Abstract]  
Schedule of calculation of earnings per share
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2013
 
2012
 
2013
 
2012
Net (loss) income attributable to Valeant Pharmaceuticals International, Inc.
$
(973,243
)
 
$
7,645

 
$
(989,907
)
 
$
(26,883
)
 
 
 
 
 
 
 
 
Basic weighted-average number of common shares outstanding (000s)
333,643

 
304,075

 
316,462

 
305,550

Diluted effect of stock options and RSUs (000s)(a)
—

 
7,361

 
—

 
—

Diluted effect of convertible debt (000s)(a)
—

 
307

 
—

 
—

Diluted weighted-average number of common shares outstanding (000s)
333,643

 
311,743

 
316,462

 
305,550

 
 
 
 
 
 
 
 
(Loss) earnings per share attributable to Valeant Pharmaceuticals International, Inc.:
 
 
 
 
 
 
 
Basic
$
(2.92
)
 
$
0.03

 
$
(3.13
)
 
$
(0.09
)
Diluted
$
(2.92
)
 
$
0.02

 
$
(3.13
)
 
$
(0.09
)
____________________________________
(a)
In the three-month and nine-month periods ended September 30, 2013 and the nine-month period ended September 30, 2012, all potential common shares issuable for stock options, RSUs and convertible debt were excluded from the calculation of diluted loss per share, as the effect of including them would have been anti-dilutive. The dilutive effect of potential common shares issuable for stock options, RSUs and convertible debt on the weighted-average number of common shares outstanding would have been as follows:
 
Three Months
Ended
September 30,
 
Nine Months
Ended
September 30,
 
Nine Months
Ended
September 30,
 
2013
 
2013
 
2012
Basic weighted-average number of common shares outstanding (000s)
333,643

 
316,462

 
305,550

Dilutive effect of stock options and RSUs (000s)
6,580

 
6,487

 
7,341

Dilutive effect of Convertible Notes (000s)
—

 
—

 
693

Diluted weighted-average number of common shares outstanding (000s)
340,223

 
322,949

 
313,584
Schedule of dilutive effect of stock options, RSUs and Convertible Notes on weighted-average number of common shares outstanding
 
Three Months
Ended
September 30,
 
Nine Months
Ended
September 30,
 
Nine Months
Ended
September 30,
 
2013
 
2013
 
2012
Basic weighted-average number of common shares outstanding (000s)
333,643

 
316,462

 
305,550

Dilutive effect of stock options and RSUs (000s)
6,580

 
6,487

 
7,341

Dilutive effect of Convertible Notes (000s)
—

 
—

 
693

Diluted weighted-average number of common shares outstanding (000s)
340,223

 
322,949

 
313,584